HIF-1 alpha (HIF1A) Human shRNA Plasmid Kit (Locus ID 3091)
CAT#: TG320380
HIF1A - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 7 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | HIF-1 alpha (HIF1A) Human shRNA Plasmid Kit (Locus ID 3091) |
Locus ID | 3091 |
UniProt ID | Q16665 |
Synonyms | bHLHe78; HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | HIF1A - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 3091). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001243084, NM_001530, NM_181054, NM_001530.1, NM_001530.2, NM_001530.3, NM_181054.1, NM_181054.2, NM_001243084.1, BC012527, BC012527.2, NM_001530.4, NM_181054.3 |
Summary | This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (7)
The use of this RNAi has been cited in the following citations: |
---|
ERK regulates HIF-1α-mediated platinum resistance by directly targeting PHD2 in ovarian cancer
,Li, Z;Zhou, W;Zhang, Y;Sun, W;Yung, MM;Sun, J;Li, J;Chen, CW;Li, Z;Meng, Y;Chai, J;Zhou, Y;Liu, SS;Cheung, AN;Ngan, HY;Chan, DW;Zheng, W;Zhu, W;,
Clin. Cancer Res.
,PubMed ID 31285371
[HIF1A]
|
Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation
,null,
American Journal of Cancer Research
,PubMed ID 27294000
[HIF1A]
|
Regulation of Noxa-mediated apoptosis in Helicobacter pylori-infected gastric epithelial cells
,Rath, S;Das, L;Kokate, SB;Pratheek, BM;Chattopadhyay, S;Goswami, C;Chattopadhyay, R;Crowe, SE;Bhattacharyya, A;,
FASEB J.
,PubMed ID 25404713
[HIF1A]
|
A Splice Variant of the Human Ion Channel TRPM2 Modulates Neuroblastoma Tumor Growth Through HIF-1/2a
,Chen, SJ;Hoffman, NE;Shanmughapriya, S;Bao, L;Keefer, K;Conrad, K;Merali, S;Takahashi, Y;Abraham, T;Hirschler-Laszkiewicz, I;Wang, J;Zhang, XQ;Song, J;Barrero, C;Shi, Y;Kawasawa, YI;Bayerl, M;Sun, T;Barbour, M;Wang, HG;Madesh, M;Cheung, JY;Miller, BA;,
J. Biol. Chem.
,PubMed ID 25391657
[HIF1A]
|
The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1
,Lin, G;Gai, R;Chen, Z;Wang, Y;Liao, S;Dong, R;Zhu, H;Gu, Y;He, Q;Yang, B;,
Eur. J. Pharmacol., Feb 2014.
,PubMed ID 24561043
[HIF1A]
|
Tirapazamine Sensitizes Hepatocellular Carcinoma Cells to Topoisomerase I Inhibitors via Cooperative Modulation of Hypoxia-Inducible Factor-1a
,Cai, TY;Liu, XW;Zhu, H;Cao, J;Zhang, J;Ding, L;Lou, JS;He, QJ;Yang, B;,
Mol. Cancer Ther. Dec 2013.
,PubMed ID 24362462
[HIF1A]
|
Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
,null,
British Journal of Cancer
,PubMed ID 20010940
[HIF1A]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...